Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry

Niels P. G. Hoedemaker*, Peter Damman, Jan Paul Ottervanger, Jan Henk E. Dambrink, A. T. Marcel Gosselink, Elvin Kedhi, Evelien Kolkman, Robbert J. de Winter, Arnoud W. J. van't Hof*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Web of Science)
Original languageEnglish
Pages (from-to)127-138
Number of pages12
JournalEuropean Heart Journal-Cardiovascular Pharmacotherapy
Volume5
Issue number3
DOIs
Publication statusPublished - Jul 2019

Keywords

  • Proton-pump inhibitors
  • Acute coronary syndrome
  • Dual antiplatelet therapy
  • Registry
  • Outcomes
  • ACUTE MYOCARDIAL-INFARCTION
  • ST-SEGMENT ELEVATION
  • DUAL-ANTIPLATELET THERAPY
  • BASE-LINE CHARACTERISTICS
  • PLATELET INHIBITION
  • CLINICAL-OUTCOMES
  • CONCOMITANT USE
  • EUROPEAN-SOCIETY
  • TASK-FORCE
  • 2017 ESC

Cite this